Loading...
Loading...
Among the 3 tracked institutional investors we monitor, CTXR (CITIUS PHARMACEUTICALS INC) is held with a combined value of $238.63K across 292,380 shares. The largest holder is VANGUARD GROUP INC with a position worth $154.82K. 1 fund increased its holdings.
Total Institutional Value
$238.63K
Total Shares Held
292,380
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $154.82K | 0.00% | +19.8% |
| 2 | BlackRock, Inc. | $62.87K | 0.00% | - |
| 3 | STATE STREET CORP | $20.94K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CTXR with a position worth $154.82K, representing 0.00% of their portfolio. In total, 3 institutional investors hold CTXR with a combined value of $238.63K.
Institutional investors hold $238.63K worth of CTXR stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $154.82K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CTXR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CTXR positions.
Last Close
$0.52
2026-07-24
YTD
-38.6%
3% of 52-week range